| 1 |
中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版)[J]. 中华结核和呼吸杂志,2020, 43(11): 918-946.
|
| 2 |
Prevots DR, Marston BJ, Salfinger M, et al. Epidemiology of nontuberculous mycobacterial lung disease in the United States, 2005-2013[J]. Annals of the American Thoracic Society, 2016, 13(10): 1682-1690.
|
| 3 |
Ewert R, Hohener H, Rieder F, et al. Sex-related differences in clinical presentation and outcomes of nontuberculous mycobacterial pulmonary disease in Europe[J]. European Respiratory Journal, 2018, 52(Suppl 62): OA1246.
|
| 4 |
李丽,王辉,马小军,等. 中国非结核分枝杆菌肺病流行病学及临床特征多中心回顾性研究[J]. 中华内科杂志,2022, 61(3): 276-282.
|
| 5 |
Conyers LE, Saunders BM. Treatment for non-tuberculous mycobacteria:challenges and prospects[J]. Front Microbiol, 2024, 15: 1394220.
|
| 6 |
Kumar K, Ponnuswamy A, Capstick TG, et al. Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management[J]. Clin Med (Lond), 2024, 24(1): 100017.
|
| 7 |
唐神结,李亮,严晓峰,等. 非结核分枝杆菌病诊断与治疗指南(2020年版)[J]. 中华结核和呼吸杂志,2020, 43(11): 918-946.
|
| 8 |
韩佳颖,覃瑶,何飞. 2013-2021年杭州某综合医院非结核分枝杆菌肺病流行状况分析[J]. 中国现代医生,2023, 61(27): 6-10,18.
|
| 9 |
胡晓亮,王思琴. 矽肺合并非结核分枝杆菌肺病1例[J]. 中华劳动卫生职业病杂志,2024, 42(3): 210-212.
|
| 10 |
Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases[J]. Indian J Med Res, 2020, 152(3): 185-226.
|
| 11 |
师凌昊,程菲,郭英华,等. 非结核分枝杆菌肺病191例临床特征[J]. 中华医院感染学杂志,2023, 33(24): 3742-3747.
|
| 12 |
陈晓红,廖小琴,吴迪,等. 福州地区非结核分枝杆菌肺病临床特征[J]. 中国感染控制杂志,2021, 20(8): 688-693.
|
| 13 |
You Y, Ni Y, Shi G. Inhaled Corticosteroids and mycobacterial infection in patients with chronic airway diseases: A systematic review and Meta-analysis[J]. Respiration, 2022, 101(10): 970-980.
|
| 14 |
赖宁,庄泽钦,钟典. 广州地区非结核分枝杆菌肺病微生物及临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2022, 15(03): 339-343.
|
| 15 |
Dhasmana DJ, Whitaker P, van der LaanR, et al. A practical guide to the diagnosis and management of suspected non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the United Kingdom[J]. NPJ Prim Care Respir Med, 2024, 34(1): 45.
|
| 16 |
欧阳国泉,陈盛松,肖祖克. 非结核分枝杆菌肺病和肺结核患者的临床特征分析[J]. 中国呼吸与危重监护杂志,2021, 20(11): 774-779.
|
| 17 |
Li X, Sun D, Liang C, et al. Characterization of non-tuberculous mycobacterial pulmonary disease and pulmonary tuberculosis in patients with AFB smear-positive sputum: A retrospective comparative study[J]. Heliyon, 2024, 10(17): e37434.
|
| 18 |
陈众众,闵凌峰,刘家昌. 应用宏基因二代测序技术诊断胞内分枝杆菌型NTM肺病一例并文献复习[J/OL]. 中华肺部疾病杂志(电子版), 2022, 15(3): 448-450.
|
| 19 |
Liu H, Zhang T, Wang Y, et al. Clinical features of patients presenting with fever of unknown origin caused by non-tuberculous mycobacterium infection[J]. J Infect Dev Ctries, 2023, 17(7): 1014-1021.
|
| 20 |
王妍,邵红霞,张凯茹,等. 天津地区106例NTM肺病患者的菌种分布及临床特征分析[J]. 天津医药,2023, 51(6): 633-637.
|
| 21 |
梅琳,刘盛盛,林文红,等. 安徽省胸科医院非结核分枝杆菌肺病菌种分布、临床特征及耐药性分析[J]. 中国抗生素杂志,2023, 48(11): 1288-1294.
|
| 22 |
洪青青,姚超,张新宝. 非结核分枝杆菌肺病患者流行病学临床特点及耐药情况分析[J/OL]. 中华肺部疾病杂志(电子版), 2022, 15(4): 506-508.
|
| 23 |
Anjos LRBD, Parreira PL, Torres PPTS, et al. Non-tuberculous mycobacterial lung disease: a brief review focusing on radiological findings[J]. Rev Soc Bras Med Trop, 2020, 53: e20200241.
|
| 24 |
韩喜琴,王敬,谭秋清,等. 93例非结核分枝杆菌肺病临床分析[J]. 中国防痨杂志,2023, 45(4): 355-361.
|
| 25 |
王飞,华朵,郭建建,等. 20212023年武汉地区非结核分枝杆菌肺病患者特征分析[J]. 中国防痨杂志,2024, 46(9): 1069-1076.
|
| 26 |
Chen S, Zhong J, Yang Q, et al. Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study[J]. BMC Infect Dis, 2024, 24(1): 1159.
|
| 27 |
Mohanty BK, Eagan TML, Aarli BB, et al. Trends in non-tuberculous mycobacterial lung disease and treatment outcomes in a low-tuberculosis prevalence setting: A retrospective analysis[J]. Pathogens, 2024, 13(4): 344.
|
| 28 |
Okoi C, Anderson ST, Mulwa S, et al. Pulmonary non-tuberculous mycobacteria in colonisation and disease in The Gambia[J]. Sci Rep, 2022, 12(1): 19523.
|
| 29 |
Ferradas A, Martí-Ortega P, Ramos-Rincón JM, et al. Non-tuberculosis mycobacterial lung disease: Analyses of 62 cases[J]. Med Clin (Barc), 2023, 160(12): 561-563.
|
| 30 |
郑旭彬,何亦凡,王丽,等. 上海市某结核病定点医院非结核分枝杆菌肺病的诊断时间及影响因素分析[J]. 中华结核和呼吸杂志,2023, 46(4): 380-387.
|
| 31 |
刘超,刁婷婷,李晓非. 2012-2022年云南地区非结核分枝杆菌肺病感染情况及耐药性分析[J]. 云南医药,2023, 44(5): 10-14.
|
| 32 |
Lopes M, Batista M, Garcia T, et al. Non-tuberculous mycobacteria:clinical and laboratory characterisation (2009 and 2019)[J]. Epidemiol Infect, 2022, 151: e8.
|
| 33 |
严瑾瑜,邹涛,郭健,等. 胞内分枝杆菌肺病与堪萨斯分枝杆菌肺病临床特征分析[J]. 结核与肺部疾病杂志,2021, 2(3): 294-297.
|
| 34 |
徐勇,陆蓉容. 鸟分枝杆菌复合群肺病和堪萨斯分枝杆菌肺病临床特点的对比研究[J]. 中外医学研究,2020,18(29): 162-164.
|
| 35 |
肖士林,赵秀芹,刘志广,等. 5种中国罕见慢速生长非结核分枝杆菌标准株及临床分离株的药物敏感性分析[J]. 疾病监测,2020, 35(5): 435-441.
|